Advances in bacterial specific imaging

Brazilian Archives of Biology and Technology

Volumn 48, Issue SPECIL ISS. 2, 2005, Pages 145-152

  Wareham, David ^a,b   Michael, J ^a   Das, Satya ^a,b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

99mTc ciprofloxacin; Infection specific imaging; Radiolabelled anti infectives; Radiopharmaceuticals

Indexed keywords

EID: 41749107463     PISSN: 15168913     EISSN: 16784324     Source Type: Journal    
DOI: 10.1590/S1516-89132005000700021     Document Type: Article

References (32)

1. 99mTc-ubiquicidin 29-41 as human infectionimaging agent: clinical trial. J Nucl Med., 46, 567-73.
2. 99mTc-ciprofloxacin. Hepatogastroenterology., 52, 491-5.
3. Ball P. Safety of the new fluoroquinolones compared with ciprofloxacin (2000). J Chemother., 12, Suppl 1:8-11.
4. -99m Methylene diphosphonate (MDP) Three-phase Bone Scintigraphy in the Diagnosis of Osteomyelitis in Patients with Sickle Cell Disease. World J Nucl Med., 2, 110-115.
5. Bettegowda C, Foss CA, Cheong I, Wang Y, Diaz L, Agrawal N, Fox J, Dick J, Dang LH, Zhou S, Kinzler KW, Vogelstein B, Pomper MG. (2005). Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'- fluoro-beta-D-arabinofuranosyl)-5-iodouracil. Proc Natl Acad Sci U S A., 102, 1145-50.
6. Britton KE, Wareham DW, Das SS, Solanki KK, Amaral H, Bhatnagar A, Katamihardja AH, Malamitsi J, Moustafa HM, Soroa VE, Sundram FX, Padhy AK. (2002). Imaging bacterial infection with (99m)Tc-ciprofloxacin (Infecton). J Clin Pathol., 55, 817-23.
7. 99mTc using a new procedure. Pharmacokinetic study in the mouse and rat. Int J Rad Appl Instrum., 41:493-6.
8. st century. Braz Arch Biol Tech, 45, 25-37.
9. Das SS, Britton KE (2003). Bacterial Specific Imaging. World J Nucl Med, 2,173-179.
10. Das SS (2005). Personal communication
11. -111 polyclonal immunoglobulin G scintigraphy in fever of unknown origin (FUO). J Nucl Med, 38, 484-489.
12. 99mTc-ciprofloxacin planar and tomographic imaging for the diagnosis of infection in the postoperative spine: experience in 48 patients. Eur J Nucl Med Mol Imaging., 31, 233-9.
13. 99mTc ciprofloxacin imaging for the diagnosis of infection in the postoperative spine. Nucl Med Commun., 25, 277-83.
14. Gnanasegaran G, Croasdale J, Buscomebe JR. (2004). Nuclear medicine in imaging infection and inflammation: Part-I, radiopharmaceuticals. World J Nucl Med., 3, 155-165.
15. 99mTc. Rev Esp Med Nucl., 19, 479-83.
16. th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, USA, 15-18.
17. 99mTc-Infecton, a novel agent for detecting sites of infection. J Clin Pathol., 51, 215-9.
18. 99mTc-ciprofloxacin kit preparation (2002). Nuklearmedizin., 41, 224-9.
19. 99mTc white blood cell and three-phase bone imaging in the diagnosis of hip prosthesis infections: improved diagnostic accuracy with extended imaging time. Nucl Med Commun., 23, 655-61.
20. -99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections. Eur J Nucl Med Mol Imaging., 29, 674-9.
21. 99mTc ciprofloxacin using a newly developed simple labelling kit. World J Nucl Med., 2, 269-274.
22. 99mTc-ciprofloxacin radiopharmaceutical for the detection of bone infection. Clin Microbiol Infect, 9, 101-9.
23. 99mTc-ciprofloxacin (infecton) scan. Vet Radiol Ultrasound., 43, 178-182.
24. 99mTc-ciprofloxacin J Nucl Med., 45, 2088-94.
25. -99m labelled sparfloxacin: A specific infection imaging agent World J Nucl Med 1, 103-109.
26. -99m Isoniazid: A specific agent for Diagnosis of tuberculosis. World J Nucl Med., 2, 292-305.
27. 99mTc-ciprofloxacin DRAXIMAGE. IDrugs., 7, 374-9.
28. 99mTc infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet, 347, 233-5.
29. -99m and its evaluation for detection of tuberculosis. World J Nucl Med., 4, 35-46.
30. Wareham D, Das S, Britton K. (2000). Imaging Infection. In: Wilcox M, editor. Fast Facts-Infection Highlights 1999-2000. Oxford: Health Press; 81-87.
31. -99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med., 27, 292-301.
32. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med., 42, 788-94.